As of 2025-09-18, the Intrinsic Value of Portage Biotech Inc (PRTG) is -21.45 USD. This PRTG valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.81 USD, the upside of Portage Biotech Inc is -415.04%.
Based on its market price of 6.81 USD and our intrinsic valuation, Portage Biotech Inc (PRTG) is overvalued by 415.04%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -21.45 - -21.45 | -21.45 | -415.04% |
| DDM - Stable | (25.08) - (74.06) | (49.57) | -827.9% |
| DDM - Multi | (13.85) - (33.93) | (19.92) | -392.4% |
| Market Cap (mil) | 15.53 |
| Beta | 2.59 |
| Outstanding shares (mil) | 2.28 |
| Enterprise Value (mil) | 13.86 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.59% |
| Cost of Debt | 5.00% |
| WACC | 8.44% |